BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34650054)

  • 1. Diet-induced obesity accelerates oral carcinogenesis by recruitment and functional enhancement of myeloid-derived suppressor cells.
    Peng J; Hu Q; Chen X; Wang C; Zhang J; Ren X; Wang Y; Tao X; Li H; Song M; Cheng B; Wu T; Xia J
    Cell Death Dis; 2021 Oct; 12(10):946. PubMed ID: 34650054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mucoadhesive celecoxib-loaded cubosomal sponges: Anticancer potential and regulation of myeloid-derived suppressor cells in oral squamous cell carcinoma.
    Mabrouk AA; El-Mezayen NS; Tadros MI; El-Gazayerly ON; El-Refaie WM
    Eur J Pharm Biopharm; 2023 Jan; 182():62-80. PubMed ID: 36513316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid derived suppressor cells contribute to the malignant progression of oral squamous cell carcinoma.
    Pang X; Fan HY; Tang YL; Wang SS; Cao MX; Wang HF; Dai LL; Wang K; Yu XH; Wu JB; Tang YJ; Liang XH
    PLoS One; 2020; 15(2):e0229089. PubMed ID: 32092078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD33
    Sun Y; Shao J; Jiang F; Wang Y; Yan Q; Yu N; Zhang J; Zhang J; Li M; He Y
    Am J Reprod Immunol; 2019 Jan; 81(1):e13067. PubMed ID: 30375700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphonuclear myeloid-derived suppressor cells and phosphatidylinositol-3 kinase gamma are critical to tobacco-mimicking oral carcinogenesis in mice.
    Nguyen KA; DePledge LN; Bian L; Ke Y; Samedi V; Berning AA; Owens P; Wang XJ; Young CD
    J Immunother Cancer; 2023 Sep; 11(9):. PubMed ID: 37734878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
    Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
    Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of Gr1+ myeloid cells attenuates high-fat-diet-aggravated esophageal squamous cell carcinoma in mice.
    Jianmin P; Qinchao H; Chunyang W; Jiayu Z; Siyu W; Li W; Juan X; Bin C
    Carcinogenesis; 2023 Oct; 44(7):587-595. PubMed ID: 37352409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-derived suppressor cells and plasmacytoid dendritic cells are associated with oncogenesis of oral squamous cell carcinoma.
    Kouketsu A; Haruka S; Kuroda K; Hitoshi M; Kensuke Y; Tsuyoshi S; Takahashi T; Hiroyuki K
    J Oral Pathol Med; 2023 Jan; 52(1):9-19. PubMed ID: 36380437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD45
    Mao FY; Zhao YL; Lv YP; Teng YS; Kong H; Liu YG; Wu XL; Hao CJ; Chen W; Duan MB; Han B; Ma Q; Wang TT; Peng LS; Zhang JY; Cheng P; Su CY; Fu XL; Zou QM; Guo G; Guo XL; Zhuang Y
    Cell Death Dis; 2018 Jul; 9(7):763. PubMed ID: 29988030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis.
    Inamoto S; Itatani Y; Yamamoto T; Minamiguchi S; Hirai H; Iwamoto M; Hasegawa S; Taketo MM; Sakai Y; Kawada K
    Clin Cancer Res; 2016 Jan; 22(2):492-501. PubMed ID: 26341919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive role of CD11b
    Hyun SY; Na EJ; Jang JE; Chung H; Kim SJ; Kim JS; Kong JH; Shim KY; Lee JI; Min YH; Cheong JW
    Cancer Med; 2020 Oct; 9(19):7007-7017. PubMed ID: 32780544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
    Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
    Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VISTA blockade alleviates immunosuppression of MDSCs in oral squamous cell carcinoma.
    Liu J; Lin WP; Xiao Y; Yang QC; Bushabu Fidele N; Yu HJ; Sun ZJ
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111128. PubMed ID: 37907049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of 4NQO-Induced Mouse Tongue Carcinogenesis by AKT Inhibitor through the MMP-9/RhoC Signaling Pathway and Autophagy.
    Yin P; Chen J; Wu Y; Gao F; Wen J; Zhang W; Su Y; Zhang X
    Anal Cell Pathol (Amst); 2022; 2022():3770715. PubMed ID: 36247874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer modulates the immunosuppressive function of CD11b
    Udumula MP; Sakr S; Dar S; Alvero AB; Ali-Fehmi R; Abdulfatah E; Li J; Jiang J; Tang A; Buekers T; Morris R; Munkarah A; Giri S; Rattan R
    Mol Metab; 2021 Nov; 53():101272. PubMed ID: 34144215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 promotes differentiation of monocytes to MDSCs via CD39/CD73-adenosine signal pathway in oral squamous cell carcinoma.
    Cui H; Lan Z; Zou KL; Zhao YY; Yu GT
    Cancer Immunol Immunother; 2023 May; 72(5):1315-1326. PubMed ID: 36436019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological blockade of HDAC6 attenuates cancer progression by inhibiting IL-1β and modulating immunosuppressive response in OSCC.
    Mahale A; Routholla G; Lavanya S; Sharma P; Ghosh B; Kulkarni OP
    Int Immunopharmacol; 2024 May; 132():111921. PubMed ID: 38547770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus.
    Chen MF; Kuan FC; Yen TC; Lu MS; Lin PY; Chung YH; Chen WC; Lee KD
    Oncotarget; 2014 Sep; 5(18):8716-28. PubMed ID: 25238263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral-specific ablation of Klf4 disrupts epithelial terminal differentiation and increases premalignant lesions and carcinomas upon chemical carcinogenesis.
    Paparella ML; Abrigo M; Bal de Kier Joffe E; Raimondi AR
    J Oral Pathol Med; 2015 Nov; 44(10):801-9. PubMed ID: 25605610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating and tumor-infiltrating myeloid-derived suppressor cells in patients with colorectal carcinoma.
    Zhang B; Wang Z; Wu L; Zhang M; Li W; Ding J; Zhu J; Wei H; Zhao K
    PLoS One; 2013; 8(2):e57114. PubMed ID: 23437326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.